Thomas J. Lynch, MD, director, Yale Cancer Center, physician-in-chief, Smilow Cancer Hospital at Yale-New Haven, Giant of Lung Cancer Care, discusses the treatment of patients with T790M-mutant non-small cell lung cancer (NSCLC).
For more resources and information regarding anticancer targeted therapies: [ Ссылка ]
Ещё видео!